During the past decade, Hitachi General Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hitachi General Hospital" #1 sponsor was "Pfizer" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hitachi General Hospital" #1 collaborator was "Chukyo Hospital" with 1 trials as a collaborator, "Ebina General Hospital" with 1 trials as a collaborator, "Hitachi General Hospital" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "Kansai Medical University" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Hitachi General Hospital" are "Multiple Myeloma" (2 trials), "Arrhythmias, Cardiac" (1 trials), "Chronic Heart Failure" (1 trials), "Diabetic Mellitus" (1 trials) and "Endometriosis" (1 trials). Many other conditions were trialed in "Hitachi General Hospital" in a lesser frequency.

Most popular intervention types in "Hitachi General Hospital" are "Drug" (8 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apremilast" (1 trials), "BAY1817080" (1 trials), "Bisoprolol" (1 trials) and "CRT-D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hitachi General Hospital" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hitachi General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hitachi General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hitachi General Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".